Phio Pharmaceuticals Statistics
Share Statistics
Phio Pharmaceuticals has 4.8M
shares outstanding. The number of shares has increased by 4.03%
in one year.
| Shares Outstanding | 4.8M |
| Shares Change (YoY) | 4.03% |
| Shares Change (QoQ) | 175.73% |
| Owned by Institutions (%) | 4.22% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 68,756 |
| FTD / Avg. Volume | 2.21% |
Short Selling Information
The latest short interest is 412.95K, so 8.61% of the outstanding
shares have been sold short.
| Short Interest | 412.95K |
| Short % of Shares Out | 8.61% |
| Short % of Float | 8.61% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1.98 and the forward
PE ratio is null.
Phio Pharmaceuticals's PEG ratio is
0.02.
| PE Ratio | -1.98 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 3 |
| P/FCF Ratio | -1.99 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Phio Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.65,
with a Debt / Equity ratio of 0.
| Current Ratio | 5.65 |
| Quick Ratio | 5.65 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.98 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,430,000 |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -69.14% in the
last 52 weeks. The beta is 0.84, so Phio Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 0.84 |
| 52-Week Price Change | -69.14% |
| 50-Day Moving Average | 1.81 |
| 200-Day Moving Average | 2.33 |
| Relative Strength Index (RSI) | 58.05 |
| Average Volume (20 Days) | 3,108,987 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.39M |
| Net Income | -7.15M |
| EBITDA | -7.12M |
| EBIT | -6.92M |
| Earnings Per Share (EPS) | -0.91 |
Full Income StatementBalance Sheet
The company has 5.38M in cash and 0 in
debt, giving a net cash position of 5.38M.
| Cash & Cash Equivalents | 5.38M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -146.36M |
| Total Assets | 13.44M |
| Working Capital | 12.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -7.11M
and capital expenditures -1K, giving a free cash flow of -7.11M.
| Operating Cash Flow | -7.11M |
| Capital Expenditures | -1K |
| Free Cash Flow | -7.11M |
| FCF Per Share | -0.9 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
